Skip to content. | Skip to navigation



About us

A premier contract development and manufacturing organization (CDMO), Vetter is a global leader in the fill & finish contract manufacturing of aseptically prefilled syringe systems, cartridges, and vials. We are a family-owned, independent company with facilities both in Germany and the US, as well as offices in Singapore and Japan. Our focus is on providing state-of-the-art manufacturing, from early clinical development and scale-up to commercial filling and packaging of parenteral drugs. We support you every step of the way, guiding your product through development, regulatory approval, launch, and life cycle management. Vetter offers you a foundation of experience spanning more than 35 years including dozens of product approvals for novel pharmaceutical and biotech compounds.

Vetter Answers


Prefilled syringes: adding unique value to compounds

Growth of prefilled syringes continues to reflect the growth in biologics, complex compounds, and increasing requirements for patients and healthcare workers. Experts project that by 2024, the prefilled market will reach 6 billion units. Prefilled syringes offer innovative delivery options, help achieve market advantages at launch, and act as a valuable life cycle management strategy.

Vetter Newsroom

Vetter provides insights into its long-term expansion plans in the US

Its initial concept intends to offer its global customer base a US manufacturing opportunity for their market supply needs of commercialized drugs.  

Vetter is a winner of the AbbVie TRIUMPH AWARD

Customer award from one of the top-20 biopharmaceutical companies was granted for meeting ‘predetermined high-level demands of service’. 


Don't miss our upcoming webinar:

Don’t let your diluent be the weakest link in your drug product

October 13 | 10am EDT

Register now!